| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.092 | 0.1 |